Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris

Psoriasis vulgaris is a common, chronic inflammatory skin disease with a prevalence of 1.5-2% in Western industrialized countries.

The goal of the Swiss S1 guidelines is to develop an informal expert consensus to provide a strategy management of sys- temic therapies by Swiss ...

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris

The present guidelines are focused on the initiation and management of systemic therapies in cases of moderate-to-severe plaque-type psoriasis in adults to ...

Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway

Tailored recommendations are given for the topical management of specific areas (scalp, facial, intertriginous/genital, or palmoplantar lesions) ...

Swiss S1 guidelines on the systemic treatment of psoriasis vulgaris

The present guidelines are focused on the initiation and management of systemic therapies in cases of moderate-to-severe plaque-type psoriasis ...

Swiss S1 guidelines on the systemic treatment of psoriasis vulgaris

The present guidelines are focused on the initiation and management of systemic therapies in cases of moderate-to-severe plaque-type psoriasis ...

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris

This first version of the Swiss S1 guidelines presents therapeutic recommendations which are based on a systematic literature search as well as ...

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris

Mentioning: 41 - Psoriasis vulgaris is a common, chronic inflammatory skin disease with a prevalence of 1.5-2% in Western industrialized countries.

Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway

Swiss S1. Guidelines on the Systemic Treatment of Pso- riasis Vulgaris. Dermatology. 2016;232(4):. 385–406. 8 Körber A, Wilsmann-Theis D ...

EuroGuiDerm Guideline on the systemic treatment of Psoriasis ...

This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and ...

EuroGuiDerm Guideline on the systemic treatment of Psoriasis ...

The EuroGuiDerm guideline on the systemic treatment of psori- asis vulgaris was developed in accordance with the EuroGui-. Derm Methods Manual v1.3, which can ...

Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway

12,15,16 Clinical practice guidelines recommend the fixed-dose combination of calcipotriol (Cal) and betamethasone dipropionate (BD) for ...

How should we do in the selection and follow-up of systemic ...

Systemic conventional treatments that are the first step in the management of moderate-to-severe plaque psoriasis include methotrexate (MTX), acitretin, ...

S3 – Guidelines on the treatment of psoriasis vulgaris (English ...

The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque‐type psoriasis in adults including systemic therapy, UV therapy and ...

Targeted treatments of psoriasis vulgaris recommended by guidelines

Kolios AG, Yawalkar N, Anliker M, et al. Swiss S1 guidelines on the systemic treatment of psoriasis vulgaris. Dermatology, 2016,232(4):385-406. doi:https://doi.

Treatment Guidelines | International Psoriasis Council

Swiss Society of Dermatology and Venereology (SGDV/SSDV) Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris Published: June 2016 (free ...

Living EuroGuiDerm Guideline for the systemic treatment of ...

Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris ... The general recommendations developed in this guideline are based on the Living ...

Basic Therapeutic Approach for Patients with Plaque Psoriasis

Swiss S1 guidelines on the systemic treatment of psoriasis vulgaris. Dermatology 2016;232:385-406. 33. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS ...

European S3-Guidelines on the systemic treatment of psoriasis ...

The distal phalanges may be destroyed during the course of the disease. Diagnostic approach. The diagnosis of psoriasis vulgaris is based almost ...

Long-term Safety of Oral Systemic Therapies for Psoriasis

Current treatment guidelines recommend a conventional oral drug as first-line systemic treatment for moderate-to-severe psoriasis, whereas a ...